Central Nervous System News and Research

RSS

Fish oil reverses age-related ailments

University of Bradford student Samantha Little has been awarded a Young Investigators Award at an international congress for her work on the effect of fish oil on the ageing brain.

25 Oct 2004

New oral vaccine treatment is effective in reducing Alzheimer's disease pathology

Alzheimer's disease is characterized by progressive loss of cognitive function due to amyloid-beta (Aß) deposits in the central nervous system. If these deposits could be stopped or slowed, Alzheimer's disease might become more manageable.

25 Oct 2004

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.

21 Oct 2004

Protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain

A protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain by transporting this agent back into the bloodstream, thus reducing the ability of this agent to reach tumors.

11 Oct 2004

Balanced diet reduces the risk of a baby with spina bifida

According to Dutch researcher Pascal Groenen, a balanced diet reduces the risk of a baby with spina bifida. He investigated how different nutritional components affected the risk of developing this condition.

11 Oct 2004

Another enterovirus 71 case confirmed in Hong Kong

The Hong Kong's Centre for Health Protection has confirmed another enterovirus 71 in a 21-month-old boy, bringing this year's total to 34. He travelled to the Mainland from September 3 to 5.

6 Oct 2004

Mouse study suggests that survivors of severe heart attacks may have problems learning certain tasks

A new study in mice suggests that survivors of severe heart attacks may have a difficult time with some learning tasks.

29 Sep 2004

Stem cells from umbilical cord blood, given intravenously with mannitol drug reduce stroke size and damage

Researchers first gave the drug, mannitol, to provide temporary passage through the blood-brain barrier then transfused human umbilical cord blood cells into a stroke animal model. When used in the first hours and days following a stroke, stroke size decreased by 40 percent and resulting disability was significantly reduced.

26 Sep 2004

Cochlear implantation leads to a higher quality of life in elderly patients

According to health care experts, cochlear implantation in senior citizens seems to be not cost effective, due to a belief that elderly patients perform poorly in the postoperative audiological rehabilitation process due to degenerative processes in the central and peripheral auditory system.

18 Sep 2004

MRI is becoming more recognized as useful in the etiological investigation of sudden deafness

For the patient, sudden deafness can be terrifying. For the specialist, this disorder can be most challenging for the cause of sudden deafness cannot be readily determined by use of the most advanced diagnostic tests.

17 Sep 2004

ChemGenex discovers five new depression genes

ChemGenex Pharmaceuticals has announced that it has filed for patent protection for a further five novel depression-associated gene targets discovered by its depression and anxiety research group.

16 Sep 2004

Red Bull energy drink does not improve a person’s physical performance

Energy drinks – usually a mixture of caffeine, taurine, carbohydrates, B-complex vitamins and gluconolactone – have become very popular in recent years.

15 Sep 2004

Important discovery that will increase the understanding of multiple sclerosis

Scientists at the University of California, Santa Barbara have made an important discovery that will increase the understanding of multiple sclerosis, a debilitating disease of the central nervous system in which the myelin sheath, an insulating membrane surrounding the nerve cells in the brain and spinal cord, start to unravel for reasons as yet unknown.

14 Sep 2004